Period | Date | Adjusted Actuals EPS | GAAP EPS |
---|---|---|---|
Q3 2022 | 2022-11-07 | Future report Set alerts | |
Q2 2022 | 2022-08-11 | -1.06 | -1.06 |
Q1 2022 | 2022-05-12 | -0.52 | -0.52 |
Q4 2021 | 2022-03-21 | -0.77 | -0.77 |
Q3 2021 | 2021-11-09 | -0.53 | -0.53 |
Q2 2021 | 2021-08-10 | -0.65 | -0.65 |
Q1 2021 | 2021-05-17 | -0.74 | -0.74 |
Q4 2020 | 2021-03-09 | -0.55 | -0.55 |
Q3 2020 | 2020-11-09 | -0.51 | -0.51 |
Q2 2020 | 2020-08-06 | -0.64 | -0.64 |
2016-06-30 | Reiterated Rating | Jefferies Group | Buy | $2.50 |
2016-06-28 | Reiterated Rating | Stifel Nicolaus | Hold | |
2016-06-14 | Reiterated Rating | Jefferies Group | Buy | $13.00 to $2.50 |
2016-06-14 | Downgrade | Goldman Sachs | Buy to Neutral | |
2016-06-14 | Downgrade | Oppenheimer | Outperform to Market Perform | |
2016-06-14 | Downgrade | RBC Capital | Outperform to Sector Perform | $14.00 to $2.00 |
2016-06-14 | Downgrade | Goldman Sachs Group Inc. | Buy to Neutral | |
2016-06-14 | Downgrade | Oppenheimer Holdings Inc. | Outperform to Market Perform | |
2016-06-14 | Downgrade | Royal Bank Of Canada | Outperform to Sector Perform | $14.00 to $2.00 |
2016-06-13 | Downgrade | Stifel Nicolaus | Buy to Hold | |
2016-05-03 | Reiterated Rating | Oppenheimer | Buy | |
2016-03-14 | Reiterated Rating | Jefferies Group | Buy | $13.00 |
2016-03-09 | Reiterated Rating | Oppenheimer | Outperform | $17.00 |
2016-03-08 | Reiterated Rating | Jefferies Group | Buy | $14.00 to $13.00 |
2016-03-08 | Lower Price Target | Stifel Nicolaus | Buy | $23.00 to $16.00 |
2016-02-02 | Reiterated Rating | Oppenheimer | Outperform | $17.00 |
2015-12-17 | Initiated Coverage | RBC Capital | Outperform | $14.00 |
2015-11-17 | Initiated Coverage | Jefferies Group | Buy | $14.00 |
2015-10-31 | Reiterated Rating | Oppenheimer | Buy | |
2015-10-30 | Lower Price Target | Oppenheimer | Outperform | $21.00 to $17.00 |
2015-08-05 | Reiterated Rating | Oppenheimer | Outperform | $12.00 to $21.00 |
2015-05-19 | Reiterated Rating | Janney Montgomery Scott | Buy | $20.00 |
2015-03-16 | Reiterated Rating | Oppenheimer | Outperform | $12.00 |
2014-09-09 | Initiated Coverage | Oppenheimer | Outperform | $12.00 |
2014-08-26 | Initiated Coverage | JMP Securities | Outperform | $14.00 |
2014-08-25 | Initiated Coverage | Stifel Nicolaus | Buy | $11.00 |
2014-08-25 | Initiated Coverage | Janney Montgomery Scott | Buy | $13.00 |
2016-06-30 | Reiterated Rating | Jefferies Group | Buy | $2.50 |
2016-06-28 | Reiterated Rating | Stifel Nicolaus | Hold | |
2016-06-14 | Reiterated Rating | Jefferies Group | Buy | $13.00 to $2.50 |
2016-06-14 | Downgrade | Goldman Sachs | Buy to Neutral | |
2016-06-14 | Downgrade | Oppenheimer | Outperform to Market Perform |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In MRNS 53 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
SUVRETTA CAPITAL MANAGEMENT, LLC | 3.54M |
venBio Select Advisor LLC | 3.15M |
Vanguard Group, Inc | 1.69M |
Bain Capital Life Sciences Investors, LLC | 1.43M |
ADAGE CAPITAL PARTNERS GP LLC | 1.24M |
683 Capital Management, LLC | 0.97M |
BlackRock Inc. | 0.96M |
TEACHERS ADVISORS INC | 0.63M |
Jefferies Group LLC | 0.49M |
Granite Point Capital Management, L.P. | 0.47M |
FRANKLIN RESOURCES INC | 0.44M |
BANK OF MONTREAL /CAN/ | 0.35M |
GEODE CAPITAL MANAGEMENT, LLC | 0.34M |
CITADEL ADVISORS LLC | 0.29M |
TIAA CREF INVESTMENT MANAGEMENT LLC | 0.26M |